These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24020352)

  • 1. Volumetric analysis of the subthalamic and red nuclei based on magnetic resonance imaging in patients with Parkinson's disease.
    Camlidag I; Kocabicak E; Sahin B; Jahanshahi A; Incesu L; Aygun D; Yildiz O; Temel Y; Belet U
    Int J Neurosci; 2014 Apr; 124(4):291-5. PubMed ID: 24020352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic and red nucleus volumes in patients with Parkinson's disease: do they change with disease progression?
    Colpan ME; Slavin KV
    Parkinsonism Relat Disord; 2010 Jul; 16(6):398-403. PubMed ID: 20452266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal activity of the red nucleus in Parkinson's disease.
    Rodriguez-Oroz MC; Rodriguez M; Leiva C; Rodriguez-Palmero M; Nieto J; Garcia-Garcia D; Luis Zubieta J; Cardiel C; Obeso JA
    Mov Disord; 2008 Apr; 23(6):908-11. PubMed ID: 18383534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3T MRI-SWI based volumetric analysis of the subthalamic and red nuclei in advanced Parkinson's disease.
    Shah V; Alugolu R; Arora A; Kandadai RM; Mudumba V; Borgohain R
    J Neurosurg Sci; 2023 Feb; 67(1):108-112. PubMed ID: 32401475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of subthalamic nuclei T2 relaxation times with neuropsychological symptoms in patients with Parkinson's disease.
    Watanabe S; Suenaga K; Yamamoto A; Abe K; Kotoura N; Ishikura R; Hirota S; Yoshikawa H
    J Neurol Sci; 2012 Apr; 315(1-2):96-9. PubMed ID: 22123154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating indirect subthalamic nucleus targeting with validated 3-tesla magnetic resonance imaging.
    Houshmand L; Cummings KS; Chou KL; Patil PG
    Stereotact Funct Neurosurg; 2014; 92(6):337-45. PubMed ID: 25358805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging-based morphometry and landmark correlation of basal ganglia nuclei.
    Zhu XL; Hamel W; Schrader B; Weinert D; Hedderich J; Herzog J; Volkmann J; Deuschl G; Müller D; Mehdorn HM
    Acta Neurochir (Wien); 2002 Oct; 144(10):959-69; discussion 968-9. PubMed ID: 12382123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of morphometric variability of subthalamic nucleus, red nucleus, and substantia nigra in advanced Parkinson's disease patients using automatic segmentation and PCA-based analysis.
    Xiao Y; Jannin P; D'Albis T; Guizard N; Haegelen C; Lalys F; Vérin M; Collins DL
    Hum Brain Mapp; 2014 Sep; 35(9):4330-44. PubMed ID: 24652699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting state fMRI reveals increased subthalamic nucleus-motor cortex connectivity in Parkinson's disease.
    Baudrexel S; Witte T; Seifried C; von Wegner F; Beissner F; Klein JC; Steinmetz H; Deichmann R; Roeper J; Hilker R
    Neuroimage; 2011 Apr; 55(4):1728-38. PubMed ID: 21255661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional MRI is inadequate to delineate the relationship between the red nucleus and subthalamic nucleus in Parkinson's disease.
    Danish SF; Jaggi JL; Moyer JT; Finkel L; Baltuch GH
    Stereotact Funct Neurosurg; 2006; 84(1):12-8. PubMed ID: 16636641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson's Disease: A 7 Tesla Imaging Study.
    Poston KL; Ua Cruadhlaoich MAI; Santoso LF; Bernstein JD; Liu T; Wang Y; Rutt B; Kerchner GA; Zeineh MM
    J Parkinsons Dis; 2020; 10(2):591-604. PubMed ID: 32250317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.
    Jin L; Wang J; Zhao L; Jin H; Fei G; Zhang Y; Zeng M; Zhong C
    Brain; 2011 Jan; 134(Pt 1):50-8. PubMed ID: 21109502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular spike microrecordings from the subthalamic area in Parkinson's disease.
    Mrakic-Sposta S; Marceglia S; Egidi M; Carrabba G; Rampini P; Locatelli M; Foffani G; Accolla E; Cogiamanian F; Tamma F; Barbieri S; Priori A
    J Clin Neurosci; 2008 May; 15(5):559-67. PubMed ID: 18378458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic nucleus--sensorimotor cortex functional connectivity in de novo and moderate Parkinson's disease.
    Kurani AS; Seidler RD; Burciu RG; Comella CL; Corcos DM; Okun MS; MacKinnon CD; Vaillancourt DE
    Neurobiol Aging; 2015 Jan; 36(1):462-9. PubMed ID: 25095723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic nuclear tissue contrast in inversion recovery MRI decreases with age in medically refractory Parkinson's disease.
    Sarkar SN; Sarkar PR; Papavassiliou E
    J Neuroimaging; 2015; 25(2):303-306. PubMed ID: 24641526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological changes in the subthalamic nucleus of people with mild-to-moderate Parkinson's disease: a 7T MRI study.
    Patriat R; Niederer J; Kaplan J; Amundsen Huffmaster S; Petrucci M; Eberly L; Harel N; MacKinnon C
    Sci Rep; 2020 May; 10(1):8785. PubMed ID: 32472044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.